BNZ-3

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameBNZ-3
Drug Alias NameBNZ-3
ClassificationBiologics
Mechanisms of ActionInterleukin-4 inhibitorsInterleukin-21 inhibitorsInterleukin-9 inhibitors
TargetsInterleukin-4Interleukin-9Interleukin-21
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioniz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioniz Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A